Back to Screener

Healthcare

Pediatrix Medical Group, Inc.(MD)

Live Price

Offline

$24.68

+2.36% today

1Y Change

+71.99%

Window

Jun 30, 2025 โ†’ Jun 26, 2026

Market Cap
$1.89B
Revenue Growth
-4.9%
EPS Growth
+263.0%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 30, 2025 โ†’ Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Pediatrix Medical Group, Inc. (MD) is a Healthcare stock with a market cap of $1.89B and listed on NYSE. The stock last traded around $24.68 and up 72.0% across the available one-year price window (Jun 30, 2025 โ†’ Jun 26, 2026). Baseline metrics include revenue growth of -4.9%, EPS growth of +263.0%, a dividend yield of 0.0%. What stands out right now is revenue -4.9%, EPS +263.0%, free cash flow +36.9% with operating margin 11.2% and ROIC 9.0%. Valuation is more restrained than many high-expectation growth names at P/E 11.6 and price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

MD vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

MD is 54.00 pts ahead over the shared 1Y window.

MD had 14.52 pts deeper max drawdown than SPY.

MD beat SPY in 2 of 2 calendar years shown and trailed in 0.

MD

+71.99%

Normalized return

SPY

+17.99%

S&P 500

Excess Return

+54.00 pts

Relative to SPY

MD Max Drawdown

-23.65%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

MDSPY

Calendar-Year Returns

Uses the longest available daily history for MD and SPY.

YearMDSPYExcessLeader
2026+15.92%+6.71%+9.22 ptsMD
2025+52.06%+11.19%+40.86 ptsMD

Unable to load analyst forecasts.

Timed out loading forecasts for MD

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.